tiprankstipranks
Advertisement
Advertisement
Maravai Lifesciences price target raised to $3 from $2 at Baird
PremiumThe FlyMaravai Lifesciences price target raised to $3 from $2 at Baird
3M ago
Balanced Risk/Reward Leads to Hold Rating as Restructuring Progress Offsets Ongoing Revenue Pressures
Premium
Ratings
Balanced Risk/Reward Leads to Hold Rating as Restructuring Progress Offsets Ongoing Revenue Pressures
3M ago
Maravai Lifesciences reports Q4 adjusted EPS (4c), consensus (7c)
Premium
The Fly
Maravai Lifesciences reports Q4 adjusted EPS (4c), consensus (7c)
3M ago
Closing Bell Movers: Inotiv surges after quarterly results
PremiumThe FlyClosing Bell Movers: Inotiv surges after quarterly results
6M ago
Maravai Lifesciences CEO buys $702.7K of class A shares
Premium
The Fly
Maravai Lifesciences CEO buys $702.7K of class A shares
6M ago
Maravai LifeSciences Earnings Call: Mixed Signals
Premium
Company Announcements
Maravai LifeSciences Earnings Call: Mixed Signals
7M ago
Maravai Lifesciences Streamlines Board with Recent Resignations
PremiumCompany AnnouncementsMaravai Lifesciences Streamlines Board with Recent Resignations
7M ago
Maravai Lifesciences’ Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Maravai Lifesciences’ Earnings Call: Growth Amid Challenges
9M ago
Maravai Lifesciences price target lowered to $5 from $7 at RBC Capital
Premium
The Fly
Maravai Lifesciences price target lowered to $5 from $7 at RBC Capital
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100